China Biologic

 
Stock Quotes for China Biologic top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Aggressive Growth
Sign-up for cbpo investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Aggressive Growth
Sign-up for cbpo investment picks

 
News Articles for China Biologic top ^
2014/3/19
BEIJING , March 19, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company has received the Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its plasma production facility at its Guizhou subsidiary.
Sign-up for China Biologic Announces Receiving GMP Certification at its Guizhou Taibang Facility investment picks
2014/3/3
BEIJING , March 3, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company has completed its repurchase of 2.5 million shares of common stock for a total consideration of $70 million .
Sign-up for China Biologic Completes Stock Repurchase Transaction investment picks
2014/4/2
BEIJING , April 2, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company has learned that the pending claim in the High Court of Hong Kong (the "Court") against Ms.
Sign-up for China Biologic Announces Favorable Resolution to Title Dispute Involving Company Shares investment picks
2Q13 Total Sales Up 6.2% / 1H Total Sales Up 10.2% 2Q13 Operating Margin Up to 47.2% / 1H Operating Margin Up to 47.7% 2Q13 Non-GAAP Net Income Up 30.8% / 1H Non-GAAP Net Income Up 29.9% Agrees to Repurchase 1.48 Million Shares BEIJING , Aug.
Sign-up for China Biologic Reports Financial Results for the Second Quarter and First Half of 2013 investment picks
2014/3/4
BEIJING , March 4, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release fourth quarter and fiscal year 2013 financial results on Wednesday, March 12, 2014 after the market closes.
Sign-up for China Biologic Products to Report Fourth Quarter and Fiscal Year 2013 Financial Results investment picks
2013/11/5
--3Q13 Total Sales of $53.2 Million / 9M Total Sales Up 6.6%-- --3Q13 Operating Income Up 13.4% / 9M Operating Income Up 23.0%-- --3Q13 Operating Margin Up 520 bp to 43.6% / 9M Operating Margin Up to 46.3% -- --3Q13 Non-GAAP Net Income Up 5.8% / 9M Non-GAAP Net Income Up 21.2%-- --Raises FY13 Adjusted Net Income Forecast--
Sign-up for China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013 investment picks
2014/3/12
-- FY13 Total Sales Up 10.0% to $203.4 Million -- --
Sign-up for China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2013 investment picks
BEIJING , Aug.
Sign-up for China Biologic to Participate in Upcoming Investor Conferences investment picks
2013/10/28
BEIJING , Oct.
Sign-up for China Biologic Products to Report Third Quarter 2013 Financial Results investment picks
2013/11/13
Levi & Korsinsky, LLP is investigating China Biologic Products, Inc. (NasdaqGS: CBPO) in connection with possible claims of breaches of fiduciary duty.
Sign-up for China Biologic Products, Inc. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc. investment picks
2014/4/8
Levi & Korsinsky, LLP is investigating China Biologic Products, Inc. (NasdaqGS: CBPO) in connection with possible claims of breaches of fiduciary duty.
Sign-up for China Biologic Products, Inc. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc. investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

China Biologic
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: China Banking  |  Next: China Business